Citation Impact
Citing Papers
New approaches and procedures for cancer treatment: Current perspectives
2021 Standout
2017 Standout
Genetic Influences on Brain Gene Expression in Rats Selected for Tameness and Aggression
2014 StandoutNobel
2,4-Dihydroxypyrimidine is a potential urinary metabolite biomarker for diagnosing bipolar disorder
2014
Expanded phenotypes and outcomes among 256 LGI 1/ CASPR 2‐ I g G –positive patients
2017
Colonic bacterial composition in Parkinson's disease
2015 Standout
Autologous Mesenchymal Stem Cell Therapy in Progressive Multiple Sclerosis: An Open Label Study
2012
Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3
2015 Standout
Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism
2016 Standout
Cellular Inclusion Bodies of Mutant Huntingtin Exon 1 Obscure Small Fibrillar Aggregate Species
2012 StandoutNobel
Infections, inflammation and epilepsy
2015
IRS2 increases mitochondrial dysfunction and oxidative stress in a mouse model of Huntington disease
2011
Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis
2014
Autoimmune Epilepsy
2012
Biological functions of mesenchymal stem cells and clinical implications
2019
Fracture healing: mechanisms and interventions
2014 Standout
MetaboAnalyst: a web server for metabolomic data analysis and interpretation
2009 Standout
Ferroptosis: Death by Lipid Peroxidation
2015 Standout
Gut microbiota functions: metabolism of nutrients and other food components
2017 Standout
Antibodies to the N-Methyl-D-Aspartate Receptor and Other Synaptic Proteins in Psychosis
2013
Stem Cell Therapies in Clinical Trials: Progress and Challenges
2015 Standout
The Lewy body in Parkinson's disease: Molecules implicated in the formation and degradation of α‐synuclein aggregates
2007
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
2017 Standout
Current trends and future requirements for the mass spectrometric investigation of microbial, mammalian and plant metabolomes
2008
Immunomodulation of mesenchymal stromal cells on regulatory T cells and its possible mechanism
2014
Parkinson's disease: clinical features and diagnosis
2008 Standout
The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis
2017
Ageing as a risk factor for neurodegenerative disease
2019 Standout
Chemometrics in metabolomics—A review in human disease diagnosis
2009
Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression
2010
Systems biology, metabolic modelling and metabolomics in drug discovery and development
2006
Mesenchymal stem cells in tumor development
2012
Parkinson's disease
2009 Standout
Imaging of autoimmune encephalitis – Relevance for clinical practice and hippocampal function
2015
Parkinson's disease
2015 Standout
Immunopathology of multiple sclerosis
2015 Standout
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Autophagy in Human Health and Disease
2013 Standout
Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature: Part 5: Neurological auto-antibodies, discussion, flow chart, conclusions
2017
Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity
2012 Standout
Myasthenia gravis
2019 Standout
Spinocerebellar ataxias caused by polyglutamine expansions: A review of therapeutic strategies
2008
Autophagy modulation as a potential therapeutic target for diverse diseases
2012 Standout
Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study
2013 Standout
Neuronal autoantigens—pathogenesis, associated disorders and antibody testing
2012
Metabolomic profiling to develop blood biomarkers for Parkinson's disease
2008
DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease
2010
Autoantibodies associated with diseases of the CNS: new developments and future challenges
2011
Non-motor features of Parkinson disease
2017 Standout
Repair and tissue engineering techniques for articular cartilage
2014 Standout
Adipose‐Derived Mesenchymal Stem Cells Exert Antiinflammatory Effects on Chondrocytes and Synoviocytes From Osteoarthritis Patients Through Prostaglandin E2
2013
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
2013 Standout
Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype
2013
A GC-TOF-MS study of the stability of serum and urine metabolomes during the UK Biobank sample collection and preparation protocols
2008
Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: A randomized, placebo-controlled, multiple-dose study
2014
Altered cholesterol and fatty acid metabolism in Huntington disease
2009
MetaboLights—an open-access general-purpose repository for metabolomics studies and associated meta-data
2012 Standout
Immune therapy in autoimmune encephalitis: a systematic review
2015
Therapies for multiple sclerosis: translational achievements and outstanding needs
2013
Discovery and resupply of pharmacologically active plant-derived natural products: A review
2015 Standout
Visual exploration in Parkinson’s disease and Parkinson’s disease dementia
2013
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry
2011 Standout
Glutathione and Parkinson's disease: Is this the elephant in the room?
2008
Preclinical Biomarkers of Parkinson Disease
2011
Metabolomic profiling using Orbitrap Fourier transform mass spectrometry with hydrophilic interaction chromatography: a method with wide applicability to analysis of biomolecules
2008
Biological fluid biomarkers in neurodegenerative parkinsonism
2009
Serum Metabolomics of Slow vs. Rapid Motor Progression Parkinson’s Disease: a Pilot Study
2013
Fingerprinting food: current technologies for the detection of food adulteration and contamination
2012 Standout
Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System
2017
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Antibody-Mediated Encephalitis
2018 Standout
Autoimmune encephalopathies
2014
Therapeutic plasma exchange as a steroid‐sparing therapy in a patient with limbic encephalitis due to antibodies to voltage‐gated potassium channels
2015
Metabolomics: A Global Biochemical Approach to Drug Response and Disease
2008
Determination of Neuronal Antibodies in Suspected and Definite Creutzfeldt-Jakob Disease
2013
Huntington's disease: from pathology and genetics to potential therapies
2008
Super-Resolution Fluorescence of Huntingtin Reveals Growth of Globular Species into Short Fibers and Coexistence of Distinct Aggregates
2014 StandoutNobel
Clinical utility of seropositive voltage-gated potassium channel–complex antibody
2016
Gut microbiota are related to Parkinson's disease and clinical phenotype
2014 Standout
Metabolomic biomarkers: search, discovery and validation
2007
Anti-LGI1–associated cognitive impairment
2016
Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Cardiovascular Epidemiology and Genetics
2015 Standout
Serum metabolomics reveals many novel metabolic markers of heart failure, including pseudouridine and 2-oxoglutarate
2007
Exploring the relationship between essential tremor and Parkinson's disease
2006
LGI Proteins in the Nervous System
2013
The Potential of Mesenchymal Stromal Cells as a Novel Cellular Therapy for Multiple Sclerosis
2012
Alpha‐synuclein protects cerebellar granule neurons against 6‐hydroxydopamine‐induced death
2007
Autoantibodies in movement and psychiatric disorders: updated concepts in detection methods, pathogenicity, and CNS entry
2015
Metabolic Fingerprinting As A Diagnostic Tool
2007
In vivo gastric detection of α‐synuclein inclusions in Parkinson's disease
2014
Oxidative Stress: A Key Modulator in Neurodegenerative Diseases
2019 Standout
Effect of Rituximab in Patients With Leucine-Rich, Glioma-Inactivated 1 Antibody–Associated Encephalopathy
2014
The recognition and treatment of autoimmune epilepsy in children
2014
Regulation of Mammalian Autophagy in Physiology and Pathophysiology
2010 Standout
Are Major Dementias Triggered by Poor Blood Flow to the Brain? Theoretical Considerations
2017
Diffusion tensor imaging in parkinsonian syndromes
2013
Works of Andrew W. Michell being referenced
Animal Models of Neurodegenerative Diseases
2009
Techniques and applications of EMG: measuring motor units from structure to function
2012
Lewy bodies in Parkinson's disease: Protectors or perpetrators?
2005
Skin and platelet α-synuclein as peripheral biomarkers of Parkinson's disease
2005
Biomarkers in Huntington's and Parkinson's Disease
2009
“The eyes have it”. Saccadometry and Parkinson's disease
2009
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study
2012
Long-term remission with rituximab in refractory leucine-rich glioma inactivated 1 antibody encephalitis
2014
Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis
2010 Standout
Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles
2006
Metabolomic analysis of urine and serum in Parkinson’s disease
2008